Security key
98943L107
Zentalis Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (ZNTL)
CUSIP: 98943L107
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 47,367,469
- Total 13F value
- $228,855,010
- Share change
- +4,503,719
- Put/Call ratio
- 4.3%
- SEC-reported price per share
- $4.85
- Number of holders
- 113
- Value change
- +$25,896,230
- Number of buys
- 61
- Number of sells
- 50
- Shares outstanding
- 94,920,069
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
113
Top holders
10
ZNTL full security history
Ownership snapshot
Full 13F holder table
Zentalis Pharmaceuticals, Inc. SEC filings
Zentalis Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
William Thurman Walters
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.9%
13D/G row: William Thurman Walters
Showing 1-6 of 15 holder rows.
Quick read
William Thurman Walters leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens William Thurman Walters's linked filing trail.
Comparable ownership
Top 5
William Thurman Walters
9.9%
5AM Opportunities II (GP), LLC
6.4%
BlackRock, Inc.
5.2%
Squadron Capital Management LLC
5.1%
VANGUARD GROUP INC
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| William Thurman Walters |
13D/G
Walters William T
|
9.9%
|
$10,081,500
7,050,000 shares
|
+$786,500 | 29 Jan 2025 |
| 5AM Opportunities II (GP), LLC |
13D/G
Andrew J. Schwab
|
6.4%
|
$7,257,856
4,838,571 shares
|
$0 | 18 Dec 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
5.2%
|
$17,997,933
3,710,914 shares
|
+$10,173,316 | 30 Jun 2026 |
| Squadron Capital Management LLC |
13D/G
13F
Squadron Master Fund LP · Company
|
5.1%
|
$9,376,095
3,676,900 shares
|
$0 | 24 Feb 2026 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
4.6%
|
$4,677,873
3,271,240 shares
|
$0 | 31 Dec 2024 |
| BARCLAYS PLC |
13D/G
13F
Company
|
3.2%
|
$9,868,110
2,263,328 shares
|
-$6,880,608 | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
113
Shares
47,367,469
Rows available
113
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
100
Q2 2026 holders
113
Holder diff
13
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|